Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Dec;74(3):387–391.

Nickel antigen induces IL-2 secretion and IL-2 receptor expression mainly on CD4+ T cells, but no measurable gamma interferon secretion in peripheral blood mononuclear cell cultures in delayed type hypersensitivity to nickel.

R Karttunen 1, S Silvennoinen-Kassinen 1, K Juutinen 1, G Andersson 1, H P Ekre 1, J Karvonen 1
PMCID: PMC1542008  PMID: 2976621

Abstract

Nickel sulphate antigen-induced peripheral blood lymphocyte activation in vitro was characterized by lymphokine measurement (IL-2, IFN-gamma) and phenotyping of the IL-2 responsive cells. Mononuclear cells from nickel-sensitive patients synthesized more DNA, produced more IL-2 and had more IL-2 receptor positive cells in response to nickel than did those of the control subjects. On the other hand no IFN-gamma was detectable in the nickel supernatants, while PPD, used as the control antigen, induced pronounced quantities of IFN-gamma with an equal amount of DNA synthesis. The increase in IL-2 receptor positive cells was due to activation of CD4+ (helper/inducer) T cells. T cells with HLA-DR antigen surface markers were more numerous on each day of culture than cells with IL-2 receptors. These two activation markers were co-expressed on the same cells only to a certain extent, thus perhaps reflecting different types or phases of activation. In conclusion, nickel-induced peripheral blood mononuclear cell activation in vitro differs from microbial antigen-induced activation with respect to its modest or non-existent IFN-gamma response.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge R. D., Sewell H. F., King G., Thomson A. W. Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation. Clin Exp Immunol. 1986 Dec;66(3):582–589. [PMC free article] [PubMed] [Google Scholar]
  2. Groenewegen G., de Ley M., Jeunhomme G. M., Buurman W. A. Supernatants of human leukocytes contain mediator, different from interferon gamma, which induces expression of MHC class II antigens. J Exp Med. 1986 Jul 1;164(1):131–143. doi: 10.1084/jem.164.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Karttunen R., Andersson G., Ekre H. P., Juutinen K., Surcel H. M., Syrjälä H., Herva E. Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination. J Clin Microbiol. 1987 Jun;25(6):1074–1078. doi: 10.1128/jcm.25.6.1074-1078.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Mertelsmann R., Welte K. Human interleukin 2: molecular biology, physiology and clinical possibilities. Immunobiology. 1986 Sep;172(3-5):400–419. doi: 10.1016/S0171-2985(86)80121-8. [DOI] [PubMed] [Google Scholar]
  5. Morhenn V. B. Keratinocyte proliferation in wound healing and skin diseases. Immunol Today. 1988 Apr;9(4):104–107. doi: 10.1016/0167-5699(88)91278-9. [DOI] [PubMed] [Google Scholar]
  6. Prince H. E., John J. K. Abnormalities of interleukin 2 receptor expression associated with decreased antigen-induced lymphocyte proliferation in patients with AIDS and related disorders. Clin Exp Immunol. 1987 Jan;67(1):59–65. [PMC free article] [PubMed] [Google Scholar]
  7. Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985 Nov;135(5):3172–3177. [PubMed] [Google Scholar]
  8. Silvennoinen-Kassinen S., Jakkula H., Karvonen J. Helper cells (Leu-3a+) carry the specificity of nickel sensitivity reaction in vitro in humans. J Invest Dermatol. 1986 Jan;86(1):18–20. doi: 10.1111/1523-1747.ep12283725. [DOI] [PubMed] [Google Scholar]
  9. Silvennoinen-Kassinen S. Lymphocyte transformation in nickel allergy: amplification of T-lymphocyte responses to nickel sulphate by macrophages in vitro. Scand J Immunol. 1980;12(1):61–65. doi: 10.1111/j.1365-3083.1980.tb00041.x. [DOI] [PubMed] [Google Scholar]
  10. Sinigaglia F., Scheidegger D., Garotta G., Scheper R., Pletscher M., Lanzavecchia A. Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. J Immunol. 1985 Dec;135(6):3929–3932. [PubMed] [Google Scholar]
  11. Troye-Blomberg M., Andersson G., Stoczkowska M., Shabo R., Romero P., Patarroyo M. E., Wigzell H., Perlmann P. Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. J Immunol. 1985 Nov;135(5):3498–3504. [PubMed] [Google Scholar]
  12. von Blomberg-van der Flier M., van der Burg C. K., Pos O., van de Plassche-Boers E. M., Bruynzeel D. P., Garotta G., Scheper R. J. In vitro studies in nickel allergy: diagnostic value of a dual parameter analysis. J Invest Dermatol. 1987 Apr;88(4):362–368. doi: 10.1111/1523-1747.ep12469023. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES